Actylis and Novo Nordisk Pharmatech A/S have entered into an agreement for the distribution of pharmaceutical grade Benzalkonium Chloride (BKC) to the pharmaceutical and medical device markets in Germany, Spain, Portugal, UK and Ireland. By combining.
According to Coherent Market Insights, the global synthetic biology market is estimated to be valued at US$ 13.9 billion in 2022 and is expected to exhibit a
Today, Novozymes and Novo Nordisk Pharmatech announce a collaboration agreement that combines the companies’ joint competencies and interests within the development of speciality enzymes for use in biopharma
Novo Nordisk Pharmatech Enters Distribution Agreement with HELM de México - Pharmaceutical Business review pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.